1. Hu, Yunxiang, Han, Jun, Ding, Shengqiang, Liu, Sanmao, Wang, Hong. 2022. Identification of ferroptosis-associated biomarkers for the potential diagnosis and treatment of postmenopausal osteoporosis. In Frontiers in endocrinology, 13, 986384. doi:10.3389/fendo.2022.986384. https://pubmed.ncbi.nlm.nih.gov/36105394/
2. Luan, Zhilin, Sun, Yang, Li, Yuyuan, Ming, Wenhua, Zhang, Ye. . Genetic association of the human MAP3K5 gene with schizophrenia in a Chinese Han population. In Psychiatric genetics, 29, 26-27. doi:10.1097/YPG.0000000000000213. https://pubmed.ncbi.nlm.nih.gov/30576298/
3. Qian, Weina, Li, Weili, Chen, Xiaoyang, Wang, Yong, Wang, Wei. 2023. Exploring the mechanism of Xingpi Capsule in diarrhea predominant-irritable bowel syndrome treatment based on multiomics technology. In Phytomedicine : international journal of phytotherapy and phytopharmacology, 111, 154653. doi:10.1016/j.phymed.2023.154653. https://pubmed.ncbi.nlm.nih.gov/36641976/
4. Lan, Tian, Hu, Yufeng, Hu, Fengjiao, Rong, Xianglu, Guo, Jiao. 2021. Hepatocyte glutathione S-transferase mu 2 prevents non-alcoholic steatohepatitis by suppressing ASK1 signaling. In Journal of hepatology, 76, 407-419. doi:10.1016/j.jhep.2021.09.040. https://pubmed.ncbi.nlm.nih.gov/34656650/
5. Tafrali, Christina, Paizi, Arsinoi, Borg, Joseph, Georgitsi, Marianthi, Patrinos, George P. . Genomic variation in the MAP3K5 gene is associated with β-thalassemia disease severity and hydroxyurea treatment efficacy. In Pharmacogenomics, 14, 469-83. doi:10.2217/pgs.13.31. https://pubmed.ncbi.nlm.nih.gov/23556445/
6. Morris, Brian J, Chen, Randi, Donlon, Timothy A, Allsopp, Richard C, Willcox, Bradley J. 2021. Lifespan extension conferred by mitogen-activated protein kinase kinase kinase 5 (MAP3K5) longevity-associated gene variation is confined to at-risk men with a cardiometabolic disease. In Aging, 13, 7953-7974. doi:10.18632/aging.202844. https://pubmed.ncbi.nlm.nih.gov/33739303/
7. Zhou, Liang, Li, Youyou, Li, Jiaren, Li, Cheng, Wang, Long. 2023. Multi-omics analysis to identify CBR3-AS1-hsa-miR-145-5p-MAP3K5 pathway as a ferroptosis-related ceRNA network in benign prostatic hyperplasia. In Genes & diseases, 11, 101184. doi:10.1016/j.gendis.2023.101184. https://pubmed.ncbi.nlm.nih.gov/38882013/
智鼠故事 
